# FDA Inspection 1098666 - Vitalant - July 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/vitalant/46ce59e9-dab9-4f9e-88b7-c67f19558bb0
Source feed: FDA_Inspections

> FDA Inspection 1098666 for Vitalant on July 18, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1098666
- Company Name: Vitalant
- Inspection Date: 2019-07-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1199227 - 2023-02-23](https://www.keypedia.com/records/fda_inspections/vitalant/70bbf3d4-9efe-4ef4-8762-ae5c6f64d512)
- [FDA Inspection 1199227 - 2023-02-23](https://www.keypedia.com/records/fda_inspections/vitalant/4d1bd294-60c4-4ef9-9686-ce0bafe7888f)
- [FDA Inspection 1013136 - 2017-05-12](https://www.keypedia.com/records/fda_inspections/vitalant/93d087d1-12e1-4ab0-a218-73082ea7e9c3)
- [FDA Inspection 926675 - 2015-04-23](https://www.keypedia.com/records/fda_inspections/vitalant/6b4f5600-7e5a-4bcb-b12a-651016349e6f)
- [FDA Inspection 815149 - 2013-01-16](https://www.keypedia.com/records/fda_inspections/vitalant/30fe9d10-7ad7-4d86-ba7a-f90cce3bc57d)

Company: https://www.keypedia.com/companies/vitalant/819be064-b04c-415c-88c3-3a478a9182b5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d